Health Care/Hospital

The Global Lung Cancer Coalition Presents the 2nd Annual Lung Cancer Journalism Awards Competition

LONDON, June 14 /Xinhua-PRNewswire/ -- The Lung Cancer Journalism Awards' mission: to raise global awareness of the leading cause of cancer-related deaths worldwide. Winners receive: -- Global showcase recognising their prize-winning work -- EUR7,000 research grant En...

2007-06-14 22:04 614

Mindray Receives FDA Approval for Two Products Targeting North American Market

SHENZHEN, China, June 14 /Xinhua-PRNewswire-FirstCall/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices in China with a rapidly growing international presence, today announced that it has received 510(k) clearance from the U.S...

2007-06-14 20:24 671

China Shenghuo Pharmaceutical Holdings, Inc. Announces Listing on American Stock Exchange and Closing of Public Offering

KUNMING, China, June 14 /Xinhua-PRNewswire-FirstCall/ -– China Shenghuo Pharmaceutical Holdings, Inc. (Amex: KUN) announced the listing of its common stock on the American Stock Exchange on Thursday, June 14, 2007, and the closing of a public offering of its common stock at an offering price o...

2007-06-14 21:00 713

Simcere Pharmaceutical Group to Acquire Additional 10% of Equity Interest in Shangdong Simcere Medgenn Bio-Pharmaceutical Co., Ltd.

NANJING, China, June 14 /Xinhua-PRNewswire/ -- Simcere Pharmaceutical Group (NYSE: SCR), a leading manufacturer and supplier of branded generic pharmaceuticals in China, and the manufacturer of innovative anti-cancer medication Endu, today announced that it has entered into an agreement to acqui...

2007-06-14 17:39 697

Skystar Receives Approval for 36 New Veterinary Medicines

XI'AN, China, June 11 /Xinhua-PRNewswire-FirstCall/ -- Skystar Bio-Pharmaceutical Co., Ltd. (OTC Bulletin Board: SKBI) ("Skystar"), a leading bio-pharmaceutical company in the People's Republic of China ("PRC"), today announced that it received approval for the production of 36 new veterinary ...

2007-06-11 20:30 594

Sundia Celebrates Strong Growth at its Third Anniversary

SHANGHAI, China, June 8 /Xinhau-PRNewswire/ -- Today Sundia Meditech Company, Ltd. celebrated its recent strong growth at the company's third anniversary party in Shanghai. The main business of this company is to provide contracted research (CRO) services to pharmaceutical and biotech compa...

2007-06-11 09:39 717

BioVeda China to Receive $10 Million Investment from Lilly Asian Ventures

SHANGHAI, China, June 6 /Xinhua-PRNewswire/ -- BioVeda China today announced a $10 Million investment from Lilly Asian Ventures. BioVeda China is the first international venture capital fund focusing on life sciences investments in China. The investment has shown Lilly's commitment to expand i...

2007-06-06 16:57 757

Chindex International Announces Conference Call to Discuss Its Fiscal 2007 Fourth Quarter and Year End Results on Wednesday, June 13, 2007

BETHESDA, Md., June 5 /Xinhua-PRNewswire/ -- Chindex International, Inc. (Nasdaq: CHDX) a leading independent American provider of Western healthcare products and services in the People's Republic of China, announced that it intends to release its financial results for the fourth quarter ende...

2007-06-05 19:30 730

Cyprotex Launches New Cloe(R) Screen Assay to Improve the Prediction of in vivo Pharmacokinetics

MANCHESTER, England, June 7 /Xinhua-PRNewswire/ -- Cyprotex announces that it has enhanced the Cloe(R) Screen product offering to include an in vitro assay that assesses the extent to which a compound binds to liver microsomes. When used in conjunction with microsomal stability data, correctio...

2007-06-07 14:00 825

Chindex International, Inc. Adopts Stockholder Rights Plan

BETHESDA, Md., June 5 /Xinhua-PRNewswire/ -- Chindex International, Inc. (Nasdaq: CHDX) announced today that its Board of Directors has adopted a Stockholder Rights Plan through the adoption of a Rights Agreement. The Rights Agreement is designed to preserve long-term values and protect...

2007-06-05 06:20 810

Pharmaxis' Aridol Gains European Approval

Asthma Product Now Approved in 14 Countries Across Europe SYDNEY, Australia, June 4 /Xinhua-PRNewswire-FirstCall/ -- The European Mutual Recognition Procedure has successfully completed evaluating the Pharmaxis (ASX: PXS; Nasdaq: PXSL) lung function test Aridol, allowing the 13 European cou...

2007-06-04 21:00 560

TaiGen Biotechnology Announces Election of New Chairman

TAIPEI, Taiwan, June 4 /Xinhua-PRNewswire/ -- TaiGen Biotechnology today announced that current board member, President and Chief Executive Officer, Dr. Ming Chu Hsu, has been unanimously elected as Chairman of the Company's Board of Directors. Dr. Hsu will assume the positi...

2007-06-04 15:36 506

U.S. Preventive Medicine(R) Commends His Highness Sheikh Mohammed Bin Rashid Al Maktoum for his Commitment to Human Development

DALLAS, June 4 /Xinhua-PRNewswire/ -- Today U.S. Preventive Medicine(R), a company working to organize and advance a culture of prevention throughout America and the world, commends the efforts of United Arab Emirates Prime Minister and Ruler of Dubai, His Highness Sheikh Mohammed Bin Ras...

2007-06-04 20:30 618

Avastin(R) Significantly Prolongs Progression Free Survival in Advanced Kidney Cancer

- Patients Have a Chance to Live Almost Twice as Long Without Their Disease Returning CHICAGO, June 4 /Xinhua-PRNewswire/ -- Adding Avastin (bevacizumab) to interferon offers patients with advanced renal cell cancer the chance to live twice as long without their disease advancing ("progress...

2007-06-04 10:27 692

Next Generation of Investigational Anti-Cancer Agents Unveiled at ASCO by AstraZeneca

ALDERLEY PARK, England, June 4 /Xinhua-PRNewswire/ -- AstraZeneca (LSN: AZN; NYSE: AZN) today announced details of two new investigational cancer therapies at the American Society of Clinical Oncology (ASCO) meeting. AZD2281 (KU-0059436) is a small molecule inhibitor of Poly-ADP Ribose Po...

2007-06-04 10:22 676

Avastin(R) Significantly Prolongs Progression Free Survival in Patients With Advanced Lung Cancer

-- Only First-line Treatment to Demonstrate Extended Survival in Over a Decade CHICAGO, June 4 /Xinhua-PRNewswire/ -- Avastin (bevacizumab), significantly improves the time patients with advanced non-small cell lung cancer (NSCLC) live without their disease advancing ("progression fr...

2007-06-04 10:00 491

New Data Show Bondronat(R) Prevents Bone Loss Caused by anastrozole in Women With Surgically Treated Breast Cancer

-- One Year Results From the ARIBON Study Presented at ASCO 2007 CHICAGO, June 6 /Xinhua-PRNewswire/ -- Bondronat(R) (ibandronic acid) has been shown to prevent bone loss caused by anastrozole in post-menopausal women given adjuvant therapy for early breast cancer according to results from ...

2007-06-04 09:59 573

Study Supports Activity of GEMZAR(R) (Gemcitabine HC1 for Injection) in the Treatment of Early-Stage Breast Cancer

Five Phase III Early-Stage Breast Cancer Studies Underway With GEMZAR CHICAGO, June 4 /Xinhua-PRNewswire/ -- GEMZAR(R) (gemcitabine HC1 for injection), approved in combination with paclitaxel (Taxol(R)) in the first-line, post-surgical treatment of metastatic breast cancer, was the subject ...

2007-06-04 09:15 606

Sinovac Issues Corporate Update

BEIJING, June 2 /Xinhua-PRNewswire/ -- Sinovac Biotech Ltd. (Amex: SVA), a vaccine-focused biotech company in China, today issued a corporate update. As previously disclosed in Sinovac’s annual report on Form 20-F, Heping Wang, a former director, owed Sinovac outstanding obligations in the...

2007-06-02 04:30 725

Jose Barella Named Executive Chairman of Merial, Ltd.

DULUTH, Ga., June 1 /Xinhua-PRNewswire/ -- The Board of Directors of Merial Ltd., one of the world's leading animal health companies, announced that Jose Barella will succeed Jerry Belle as Executive Chairman of Merial, effective June 1st. Barella has been serving Merial as Chief Oper...

2007-06-01 13:48 730
1 ... 710711712713714715716 ... 723

Week's Top Stories